Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Dietary Supplements Market Insights
3.1. Dietary Supplements – Industry snapshot
3.2. Dietary Supplements - Ecosystem analysis
3.3. Dietary Supplements Market Dynamics
3.3.1. Dietary Supplements – Market Forces
3.3.1.1. Dietary Supplements Market Driver Analysis
3.3.1.2. Dietary Supplements Market Restraint/Challenges analysis
3.3.1.3. Dietary Supplements Market Opportunity Analysis
3.3.2. Industry analysis - Porter's five force
3.3.2.1. Bargaining power of supplier
3.3.2.2. Bargaining power of buyer
3.3.2.3. Threat of substitute
3.3.2.4. Threat of new entrant
3.3.2.5. Degree of competition
3.3.3. Dietary Supplements s Market PEST Analysis, 2019
3.3.4. Dietary Supplements Market Value Chain Analysis
3.3.5. Dietary Supplements Industry Trends
3.3.6. Competitive Ranking Analysis
4. Dietary Supplements Market Size and Forecast, 2017-2026 by Type
4.1. Key Findings
4.2. Vitamins
4.3. Minerals
4.4. Amino Acids
4.5. Botanicals
4.6. Others
5. Dietary Supplements Market Size and Forecast, 2017-2026 by Form
5.1. Key Findings
5.2. Tablets
5.3. Capsules
5.4. Powder
5.5. Soft Gels
5.6. Liquids
5.7. Others
6. Dietary Supplements Market Size and Forecast, 2017-2026 by Distribution Channel
6.1. Key Findings
6.2. Offline Stores
6.3. Online Platforms
7. Dietary Supplements Market Size and Forecast, 2017-2026 by End-Users
7.1. Key Findings
7.2. Adults
7.3. Children
7.4. Infant
7.5. Pregnant Women
7.6. Geriatric
8. Dietary Supplements Market Size and Forecast, 2017-2026 by Region
8.1. Key Findings
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. UK
8.3.3. France
8.3.4. Italy
8.3.5. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.6. Middle East & Africa
9. Company Profiles
9.1. Abott Laboratories
9.1.1. Overview
9.1.2. Financials
9.1.3. Product Benchmarking
9.1.4. Recent Developments
9.2. GlaxoSmithKline
9.2.1. Overview
9.2.2. Financials
9.2.3. Product Benchmarking
9.2.4. Recent Developments
9.3. Herbalife International
9.3.1. Overview
9.3.2. Financials
9.3.3. Product Benchmarking
9.3.4. Recent Developments
9.4. Bayer AG
9.4.1. Overview
9.4.2. Financials
9.4.3. Product Benchmarking
9.4.4. Recent Developments
9.5. Pfizer Inc.
9.5.1. Overview
9.5.2. Financials
9.5.3. Product Benchmarking
9.5.4. Recent Developments
9.6. Nutraceutics Inc.
9.6.1. Overview
9.6.2. Financials
9.6.3. Product Benchmarking
9.6.4. Recent Developments
9.7. Glanbia Nutritionals
9.7.1. Overview
9.7.2. Financials
9.7.3. Product Benchmarking
9.7.4. Recent Developments
9.8. Amway
9.8.1. Overview
9.8.2. Financials
9.8.3. Product Benchmarking
9.8.4. Recent Developments
9.9. Carlyle Group
9.9.1. Overview
9.9.2. Financials
9.9.3. Product Benchmarking
9.9.4. Recent Developments
9.10. Arkopharma Laboratoires Pharmaceutiques
9.10.1. Overview
9.10.2. Financials
9.10.3. Product Benchmarking
9.10.4. Recent Developments
9.11. Bionova Lifesciences
9.11.1. Overview
9.11.2. Financials
9.11.3. Product Benchmarking
9.11.4. Recent Developments
9.12. Danisco A/S
9.12.1. Overview
9.12.2. Financials
9.12.3. Product Benchmarking
9.12.4. Recent Developments
